Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05090748 · ClinicalTrials.gov registry record
Study for the Assessment of the Quality of Echocardiographic Clips.
A clinical trial, sponsored by UltraSight.
- Completed
- Registry status
- 240
- Enrollment target
NCT05090748: Completed study, sponsored by UltraSight.
NCT05090748 is a clinical trial that has completed, run by UltraSight. The registered enrollment target is 240 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05090748 has completed, sponsored by UltraSight.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
This study main objective is to evaluate the safety and efficacy of the UltraSight AI Guidance software. The investigational product is a software that guides the user to capture a high quality ultrasound image. The study will include healthcare professionals, not specialized in echocardiography, who will perform echocardiography by using UltraSight AI Guidance software, on subjects in the medical centers cardiac units.
Primary Outcome
The expert cardiologists will evaluate whether the echo examination quality obtained by novice users has sufficient to evaluate each of the primary endpoints: 1. Sufficient quality to assess Left Ventricular (LV) size: (YES/NO) 2. Sufficient quality to assess LV function: (Yes/No) 3. Sufficient quality to assess Right Ventricular size: (Yes/No) 4. Sufficient quality to assess presence of non-trivial pericardial effusion: (Yes/No)
Interventions
- DEVICE Echocardiographic.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2022-05-15 |
| Est. Completion | 2022-08-31 |
What the finished NCT05090748 record still lists
NCT05090748 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Echocardiographic. is the first listed.
NCT05090748 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05090748 about?
NCT05090748 is a clinical study titled "Study for the Assessment of the Quality of Echocardiographic Clips.". This study main objective is to evaluate the safety and efficacy of the UltraSight AI Guidance software. The investigational product is a software that guides the user to capture a high quality ultrasound image. The study will include healthcare professionals, not specialized in echocardiography, wh...
What is the current status of trial NCT05090748?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2022-05-15. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT05090748?
The interventions under investigation include: Echocardiographic. (DEVICE).
Who is sponsoring clinical trial NCT05090748?
This trial is sponsored by UltraSight, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI